Literature DB >> 24790140

Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells.

Vidya Gadang1, Eddy Konaniah1, David Y Hui1, Anja Jaeschke2.   

Abstract

OBJECTIVE: Mitogen-activated protein kinase pathways play an important role in neointima formation secondary to vascular injury, in part by promoting proliferation of vascular smooth muscle cells (VSMC). Mixed-lineage kinase 3 (MLK3) is a mitogen-activated protein kinase kinase kinase that activates multiple mitogen-activated protein kinase pathways and has been implicated in regulating proliferation in several cell types. However, the role of MLK3 in VSMC proliferation and neointima formation is unknown. The aim of this study was to determine the function of MLK3 in the development of neointimal hyperplasia and to elucidate the underlying mechanisms. APPROACH AND
RESULTS: Neointima formation was analyzed after endothelial denudation of carotid arteries from wild-type and MLK3-deficient mice. MLK3 deficiency promoted injury-induced neointima formation and increased proliferation of primary VSMC derived from aortas isolated from MLK3-deficient mice compared with wild-type mice. Furthermore, MLK3 deficiency increased the activation of p63Rho guanine nucleotide exchange factor, RhoA, and Rho kinase in VSMC, a pathway known to promote neointimal hyperplasia, and reconstitution of MLK3 expression attenuated Rho kinase activation. Furthermore, cJun NH2-terminal kinase activation was decreased in MLK3-deficient VSMC, and proliferation of wild-type but not MLK3 knockout cells treated with a cJun NH2-terminal kinase inhibitor was attenuated.
CONCLUSIONS: We demonstrate that MLK3 limits RhoA activation and injury-induced neointima formation by binding to and inhibiting the activation of p63Rho guanine nucleotide exchange factor, a RhoA activator. In MLK3-deficient cells, activation of p63Rho guanine nucleotide exchange factor proceeds in an unchecked manner, leading to a net increase in RhoA pathway activation. Reconstitution of MLK3 expression restores MLK3/p63Rho guanine nucleotide exchange factor interaction, which is attenuated by feedback from activated cJun NH2-terminal kinase.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  mitogen-activated protein kinase kinase kinase; neointima

Mesh:

Substances:

Year:  2014        PMID: 24790140      PMCID: PMC4084683          DOI: 10.1161/ATVBAHA.114.303439

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  49 in total

1.  Role of the mixed-lineage protein kinase pathway in the metabolic stress response to obesity.

Authors:  Shashi Kant; Tamera Barrett; Anastassiia Vertii; Yun Hee Noh; Dae Young Jung; Jason K Kim; Roger J Davis
Journal:  Cell Rep       Date:  2013-08-15       Impact factor: 9.423

2.  Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase.

Authors:  V Sauzeau; E Le Mellionnec; J Bertoglio; E Scalbert; P Pacaud; G Loirand
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

3.  Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

Authors:  F C Tanner; M Boehm; L M Akyürek; H San; Z Y Yang; J Tashiro; G J Nabel; E G Nabel
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

4.  Cdc42-induced activation of the mixed-lineage kinase SPRK in vivo. Requirement of the Cdc42/Rac interactive binding motif and changes in phosphorylation.

Authors:  B C Böck; P O Vacratsis; E Qamirani; K A Gallo
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

5.  Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries.

Authors:  N Sawada; H Itoh; K Ueyama; J Yamashita; K Doi; T H Chun; M Inoue; K Masatsugu; T Saito; Y Fukunaga; S Sakaguchi; H Arai; N Ohno; M Komeda; K Nakao
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

6.  MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice.

Authors:  Weiguo Zou; Matthew B Greenblatt; Jae-Hyuck Shim; Shashi Kant; Bo Zhai; Sutada Lotinun; Nicholas Brady; Dorothy Zhang Hu; Steven P Gygi; Roland Baron; Roger J Davis; Dallas Jones; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

7.  Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.

Authors:  Samar H Ibrahim; Gregory J Gores; Petra Hirsova; Michelle Kirby; Lili Miles; Anja Jaeschke; Rohit Kohli
Journal:  Liver Int       Date:  2013-11-20       Impact factor: 5.828

8.  Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury.

Authors:  N Ohashi; A Matsumori; Y Furukawa; K Ono; M Okada; A Iwasaki; T Miyamoto; A Nakano; S Sasayama
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

9.  MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet.

Authors:  Vidya Gadang; Rohit Kohli; Andriy Myronovych; David Y Hui; Diego Perez-Tilve; Anja Jaeschke
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-07-16       Impact factor: 4.310

10.  Loss of MLK3 signaling impedes ulcer healing by modulating MAPK signaling in mouse intestinal mucosa.

Authors:  Pavlo L Kovalenko; Lyudmyla Kunovska; Jian Chen; Kathleen A Gallo; Marc D Basson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-23       Impact factor: 4.052

View more
  7 in total

1.  Mixed lineage kinase 3 requires a functional CRIB domain for regulation of blood pressure, cardiac hypertrophy, and left ventricular function.

Authors:  Pei-Wen Liu; Gregory L Martin; Weiyu Lin; Wanting Huang; Suchita Pande; Mark J Aronovitz; Roger J Davis; Robert M Blanton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-07-22       Impact factor: 5.125

2.  Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice.

Authors:  Vijaya Karoor; Mehdi A Fini; Zoe Loomis; Timothy Sullivan; Louis B Hersh; Evgenia Gerasimovskaya; David Irwin; Edward C Dempsey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-30       Impact factor: 8.311

3.  microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.

Authors:  Timothy D Calamaras; Robert A Baumgartner; Mark J Aronovitz; Angela L McLaughlin; Kelly Tam; Daniel A Richards; Craig W Cooper; Nathan Li; Wendy E Baur; Xiaoying Qiao; Guang-Rong Wang; Roger J Davis; Navin K Kapur; Richard H Karas; Robert M Blanton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-26       Impact factor: 4.733

5.  Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis.

Authors:  Scott D Collum; Ning-Yuan Chen; Adriana M Hernandez; Ankit Hanmandlu; Heather Sweeney; Tinne C J Mertens; Tingting Weng; Fayong Luo; Jose G Molina; Jonathan Davies; Ian P Horan; Nick W Morrell; Javier Amione-Guerra; Odeaa Al-Jabbari; Keith Youker; Wenchao Sun; Jayakumar Rajadas; Paul L Bollyky; Bindu H Akkanti; Soma Jyothula; Neeraj Sinha; Ashrith Guha; Harry Karmouty-Quintana
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

6.  Genetic colocalization atlas points to common regulatory sites and genes for hematopoietic traits and hematopoietic contributions to disease phenotypes.

Authors:  Christopher S Thom; Benjamin F Voight
Journal:  BMC Med Genomics       Date:  2020-06-29       Impact factor: 3.063

7.  MLK3 mediates impact of PKG1α on cardiac function and controls blood pressure through separate mechanisms.

Authors:  Timothy D Calamaras; Suchita Pande; Robert Au Baumgartner; Seung Kyum Kim; Joseph C McCarthy; Gregory L Martin; Kelly Tam; Angela L McLaughlin; Guang-Rong Wang; Mark J Aronovitz; Weiyu Lin; Jonathan I Aguirre; Paulina Baca; Peiwen Liu; Daniel A Richards; Roger J Davis; Richard H Karas; Iris Z Jaffe; Robert M Blanton
Journal:  JCI Insight       Date:  2021-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.